Jenscare Scientific Co., Ltd.

SEHK:9877 Stock Report

Market Cap: HK$1.3b

Jenscare Scientific Past Earnings Performance

Past criteria checks 0/6

Jenscare Scientific's earnings have been declining at an average annual rate of -3.1%, while the Medical Equipment industry saw earnings growing at 14.7% annually.

Key information

-3.1%

Earnings growth rate

6.9%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth raten/a
Return on equity-28.7%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Here's Why We're Not At All Concerned With Jenscare Scientific's (HKG:9877) Cash Burn Situation

May 15
Here's Why We're Not At All Concerned With Jenscare Scientific's (HKG:9877) Cash Burn Situation

Companies Like Jenscare Scientific (HKG:9877) Are In A Position To Invest In Growth

Jan 11
Companies Like Jenscare Scientific (HKG:9877) Are In A Position To Invest In Growth

Revenue & Expenses Breakdown

How Jenscare Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:9877 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-298103233
31 Mar 240-335127260
31 Dec 230-372150288
30 Sep 230-457206316
30 Jun 230-542261345
31 Mar 230-491240318
31 Dec 220-439220292
30 Sep 220-322154228
30 Jun 220-20589165
31 Mar 220-353164215
31 Dec 210-501239265

Quality Earnings: 9877 is currently unprofitable.

Growing Profit Margin: 9877 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9877 is unprofitable, and losses have increased over the past 5 years at a rate of 3.1% per year.

Accelerating Growth: Unable to compare 9877's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9877 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).


Return on Equity

High ROE: 9877 has a negative Return on Equity (-28.65%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies